Introduction
============

The past decade has seen a large increase in the list of immunological components detected in human breast milk [@B1]. Large quantities of secretory immunoglobulins (particularly IgA), measurable levels of leukocytes, as well as antimicrobial factors (such as lysozyme, lactoferrin and oligosaccharides) are abundant in breast milk [@B2]. These immune-related factors not only provide passive immunity to infants, but could also prompt and modulate the development of the infant\'s own immune system.

Exosomes are tiny endosome-derived membrane vesicles (\~30-100 nm in diameter) that are released into the extracellular environment from a variety of different cells [@B3], [@B4]. Exosomes are present in various body fluids (such as amniotic fluid, blood, malignant ascites fluid, milk, saliva and urine) and contain distinct subsets of microRNAs (miRNAs) [@B5]. miRNAs, a large family of \~22 nucleotide (nt) non-coding small RNAs, are derived from \~70 nt long stem-loop precursors (pre-miRNAs), have emerged as key post-transcriptional regulators of gene expression and play important roles in a wide range of physiological and pathological processes [@B6]. Circulating miRNA levels have been found to be elevated in diseased states, such as ovarian cancer, lung cancer and melanoma [@B7]-[@B9]. The finding that miRNAs are present in exosomes triggered the hypothesis that extracellular miRNAs may function in cell-cell communication [@B4], [@B10].

In the present study, we investigated the miRNA transcriptome of exosomes in human breast milk using deep sequencing technology to elucidate the distribution and expression profile of immune-related miRNAs. Particular emphasis was placed on the resistance and stability of breast milk miRNAs under different harsh conditions.

Materials and Methods
=====================

Ethics statement
----------------

All women involved in the study gave their signed informed consent to participate. The study was approved by the ethics committees of Ya\'an Vocational College and the College of Animal Science and Technology, Sichuan Agricultural University.

Sample collection
-----------------

Human breast milk samples (20-50 ml) were collected into sterile tubes using a manual breast pump from four healthy women (30 ± 0.9 years old, primiparity) when their infants were aged 60 days. Smoking or medication during pregnancy, known autoimmune disorders, diabetes, or allergic asthma excluded women from participation in this study. All samples were stored at -80 °C until analyzed. All mothers had full term vaginal deliveries of healthy, normal birth-weight infants.

Enrichment of exosomal RNA in breast milk
-----------------------------------------

Raw milk (1.5 ml) was centrifuged at 2,000 × g for 10 min to remove fat globules. The supernatant was centrifuged at 12,000 × g for 30 min and further filtered through a 0.45 μm PVDF filter to eliminate cells and cellular debris. Approximately 1 ml of supernatant was mixed with 500 µl of ExoQuick Exosome Precipitation Solution (SBI, CA, USA) and incubated at 4 °C for 12 hours. The ExoQuick/supernatant mixture was centrifuged at 1,500 × g for 30 min to obtain a beige exosome pellet, which was then re-suspended in 250 µl nuclease-free water. Total RNA from exosomes was extracted using TRIzol-LS (Invitrogen, CA, USA) following the manufacturer\'s instructions. Small RNAs were analyzed with the Agilent Bioanalyzer 2100 and the RNA 6000 Nano LabChip Kit (Agilent, CA, USA).

Small RNA sequencing
--------------------

Total RNA isolated from each woman\'s milk was used for library construction and subjected to single-end sequencing in 36 bp reads using an Illumina Genome Analyzer II. The bioinformatics pipeline for miRNA discovery and profiling was carried out as previously described [@B11], [@B12]. In brief, the raw reads that passed through a series of filters (such as the length and sequence comparison) were called "mappable reads". All mappable reads were counted and the identical reads were combined into a single kind, and then were mapped to the 1,424 human pre-miRNAs registered in miRBase 17.0 (April 2011) with no more than one mismatch. As our previous reports [@B11], [@B12], the most abundant mature variant of a given miRNA was chosen as a reference sequence, which provides the most robust approach for evaluation of expression level. The small RNA sequence data from this study have been submitted to the NCBI Gene Expression Omnibus under accession no. GSE32253.

Harsh treatments of miRNAs and quantitative PCR (q-PCR)
-------------------------------------------------------

Three exogenous miRNAs (ath-miR-159a-3p of *A. thaliana*, cel-lin-4-5p and cel-miR-2-3p of *C. elegans*), which have no sequence similarity to human miRNAs, were chemically synthesized. To determine the resistance and stability of exogenous miRNAs, ath-miR-159a-3p was added directly to raw milk and subjected to four types of treatment: (1) incubated at 26 °C for 0.5, 1, 2, 4, 8 and 24 hours; (2) subjected to six freeze-thaw cycles at -20 °C; (3) treated with RNase A (0.16 µg·µl^-1^) and RNase T1 (0.4 U·µl^-1^) (Fermentas, Shenzhen, China) for 60 min at 37 °C; and (4) incubated at 100 °C for 10 min. After these treatments, in order to normalize inter-sample variation in the RNA isolation step, cel-lin-4-5p and cel-miR-2-3p were added to the raw milk after the addition of TRIzol-LS (Invitrogen, CA, USA), which contains RNase inhibitors.

EvaGreen-based q-PCR was performed with a High-Specificity miRNA qRT-PCR Detection Kit (Stratagene, CA, USA) on the CFX96™ Real-Time PCR Detection System (Bio-Rad, CA, USA). The forward primers of the three exogenous and ten endogenous miRNAs were identical in sequence and length to the miRNAs themselves. The ΔΔCt method was used to determine expression level differences between surveyed samples. Each miRNA of each sample was analyzed in triplicate.

Results and Discussion
======================

An overview of exosomal miRNAs in milk
--------------------------------------

Four exosomal small RNA libraries were generated from the milk of four women and each library was individually sequenced. This generated \~21.59 million (M) 36 nt reads. The four libraries produced \~86.37 M raw reads and of these, 96.70% (\~83.52 M) passed through filters for sequence patterns (simple sequence compositions) of length, copy number and other known RNA classes, and are referred to as "mappable reads" [@B11], [@B12]. Similar to previous studies on different tissue types [@B11], [@B12], the majority of the small RNAs in breast milk exosomes are 20-24 nt in size, with the predominant species being 22 nt in length (65.56 ± 7.65%), which is typical of Dicer-processed products (Fig. [1](#F1){ref-type="fig"}).

Analysis of the mapped human pre-miRNAs indicates that 452 of 1,424 (\~31.74%) known human pre-miRNAs deposited in the latest version of miRBase 17.0 were detected in the four exosomal small RNA libraries (Fig. [2](#F2){ref-type="fig"}A). Predictably, we detected identical mature miRNA sequences that originate from distinct pre-miRNAs; 639 mature miRNAs originating from 452 pre-miRNAs were identified, corresponding to 602 unique miRNAs.

The biological replicates were highly correlated with each other (average *r* = 0.94) (Table [1](#T1){ref-type="table"}), which suggested experimental reliability and further highlighted the low variation in exosomal miRNA profiles in breast milk across different healthy individuals.

Immune-related miRNAs are enriched in breast milk exosomes
----------------------------------------------------------

The miRNA transcriptome in breast milk exosomes consists of unevenly distributed counts of reads, varying from millions of reads for the highest expression to single count miRNAs. The ten most highly expressed unique miRNAs account for 62.3 % of the total counts for all 602 unique miRNAs (Fig. [2](#F2){ref-type="fig"}B).

Notably, four of the top ten miRNAs (1^st^: miR-148a-3p; 2^nd^: miR-30b-5p; 8^th^: miR-182-5p; and 9^th^: miR-200a-3p) are designated as immune-related pre-miRNAs based on the annotation of the Pathway Central database (SABiosciences, MD, USA). miR-30b-5p promotes cellular invasion and immunosuppression [@B13]; miR-182-5p is induced by IL-2 (interleukin-2) and promotes T cell-mediated immune responses [@B14]; and miR-200a-3p is associated with Hodgkin lymphoma [@B15] and oral cancers [@B16]. Specifically, miR-148a-3p was the most highly expressed miRNA over all four libraries and, on average, accounts for \~35.45 % of the total counts of all 602 unique miRNAs. This is consistent with a previous report showing that miR-148a-3p was highly expressed in bovine milk and was identified as a potential biomarker for the quality control of raw milk and other milk-related products [@B17]. Intriguingly, direct protein coding gene targets of miR-148a-3p so far reported include *TGIF2* (TGFB-induced factor homeobox 2), which is overexpressed in ovarian cancer [@B18] and *PXR* (pregnane X receptor), a major transcription factor regulating the inducible expression of a variety of transporters and drug-metabolizing enzymes [@B19]. Interestingly, *DNMT3B* (DNA methyltransferase 3b), which encodes a *de novo* methyltransferase that sets up DNA methylation patterns early in development, is another known target of miR-148a [@B20]. A recent study showed that the exogenous plant miRNAs in food are present in the sera and tissues of various animals, and can regulate the expression of target genes in mammals [@B21]. Therefore, we tentatively speculate that the enrichment of these highly expressed miRNAs in human breast milk lead to a post-transcriptional repression of their target genes in cells of the infant digestive tract.

Recent reports indicate that other miRNAs in the top ten are also related to various pathological responses. For example, miR-29a-3p suppresses immune responses to intracellular pathogens by targeting interferon-*γ* [@B22]; plasma miR-141-3p was identified as a potential biomarker for colon cancers [@B23]; miR-378-3p acts as a molecular switch involved in breast cancer cell metabolism via interference with a well-integrated bioenergetics transcriptional pathway [@B24], and miR-146b-5p targets NF-κB signaling in innate immune responses [@B25].

In addition, two of the top ten miRNAs are from the ubiquitous let-7-family of miRNAs (let-7f-1-5p & -2-5p, and let-7a-2-5p & -3-5p), which are key miRNA regulators in development that are present in abundance across various species, including mammals, flies, worms and plants [@B26].

The distribution of pre-miRNAs in breast milk exosomes shows that more than half of the immune-related pre-miRNAs (59 of 87, 67.82%) are present and enriched in breast milk exosomes (*P* \< 10^-16^, *χ*^2^ test) (Fig. [2](#F2){ref-type="fig"}A, C), which is consistent with previous studies [@B27]. Interestingly, six pre-miRNAs from the miR-17-92 cluster and nine pre-miRNAs from paralogous clusters were both abundant in breast milk exosomes (Fig. [2](#F2){ref-type="fig"}D). In addition to being well-known oncogenes, recent studies establish essential roles for the miR-17-92 and paralogous clusters in development of the immune system [@B28]. In contrast, tissue-specific miRNAs were generally less abundant in breast milk exosomes (Fig. [2](#F2){ref-type="fig"}E).

Previous reports suggested that exosomes play a significant role in intercellular communication by transferring miRNAs to neighboring cells [@B4], [@B10]. Although the molecular mechanism underlying this phenomenon is still unclear, it is intriguing to speculate that the these immune-related miRNAs in milk exosomes may be transferred into the infant body via the digestive tract, and may play a critical role in the development of the immune system in infants.

Resistance to degradation and stability of breast milk miRNAs
-------------------------------------------------------------

We next sought to investigate the stability of miRNAs in breast milk, given that it is an important prerequisite for our hypothesis that these exosomal miRNAs are transferable genetic material from mother to infant.

Similar to previous studies on blood [@B29], [@B30], the exogenous synthetic miRNAs were rapidly degraded, whereas endogenous miRNAs remain stable when milk is subjected to prolonged room temperature incubation (Fig. [3](#F3){ref-type="fig"}A) or freeze-thawed multiple times (Fig. [3](#F3){ref-type="fig"}B). Furthermore, compared with the complete degradation of exogenous miRNAs by treatment with RNase (Fig. [3](#F3){ref-type="fig"}C) or by incubation at 100°C for 10 min (Fig. [3](#F3){ref-type="fig"}D), the endogenous miRNAs are resistant to a certain extent to the harsh conditions.

Conclusion
==========

The present study provides a close look at the immune-related miRNAs which are enriched in breast milk exosomes, and evidence that these exosomal miRNAs are resistant to general harsh conditions, such as prolonged room temperature incubation, multiple freeze-thaw, RNase digestion and even boiling. We tentatively propose that these exosomal miRNAs are transferable genetic material from mother to infant, and are essential for the development of the immune system in infants.
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**Distribution and characterization of miRNAs in breast milk exosomes. *(A)*** Distribution of pre-miRNAs. Out of 1,424 pre-miRNAs deposited in miRBase 17.0 (blue circle), 87 (6.11%) pre-miRNAs have been designated as immune-related pre-miRNAs based on annotation in the Pathway Central database (SABiosciences, MD, USA). Immune-related pre-miRNAs (59 of 452, 13.05%) are enriched in breast milk exosomes (red circle). *χ*^2^ test: Number of immune-related miRNAs and others detected in breast milk exosomes compared with the total entries in miRBase 17.0. **(*B*)**Top ten most highly expressed unique miRNAs. Plot of the unique miRNAs (starting from the miRNA with the highest counts, x-axis) versus their cumulative % of the total counts from 602 unique miRNAs detected in breast milk exosomes for each small RNA library. Values are means ± s.d. The dashed horizontal line at 62.3% represents the level of the top ten unique miRNAs and the % of individual miRNAs is marked by the gray line.**(*C*-*E*)**The expression profile of selected miRNAs in breast milk exosomes. **(*C*)** 59 immune-related pre-miRNAs; **(*D*)** miR-17-92 cluster and paralogous clusters, and **(*E*)** ten well-characterized tissue-specific pre-miRNAs.
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**Characterization of breast milk miRNAs.**The expression changes of a spiked-in *C. elegans* miRNA and of the top ten most highly expressed unique miRNAs from the small RNA libraries across various harsh conditions. Total RNA was extracted and then analyzed by q-PCR. Breast milk was (***A***) incubated at 26°C for 0.5, 1, 2, 4, 8 or 24 hours, (***B***) subjected to six freeze-thaw cycles at -20°C, (***C***) treated with RNase A and T1 for 60 min at 37°C, and (***D***) incubated at 100°C for 10 min.
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###### 

Pearson\'s correlation of the counts of 602 unique miRNAs among four biological replicates. (\*\*: *P* \< 10^-16^)

  Sample No.   2            3            4
  ------------ ------------ ------------ ------------
  1            0.93^\*\*^   0.95^\*\*^   0.89^\*\*^
  2                         0.98^\*\*^   0.94^\*\*^
  3                                      0.96^\*\*^
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